Key result
Exosomes from adipose-derived stem cells promoted angiogenesis and improved outcomes in mouse models of ischemic hindlimb and myocardial infarction via miR-31-mediated HIF-1α activation.
Why the study?
Following findings that adipose-derived stem cell exosomes promote angiogenesis via miR-31 targeting FIH1, it was hypothesized that they alleviate ischemic diseases through the miR-31/FIH1/HIF-1α signaling pathway.
Do exosomes from adipose-derived stem cells promote angiogenesis and alleviate myocardial infarction via the miR-31/FIH1/HIF-1α pathway in ischemic mouse models?
Do exosomes from adipose-derived stem cells promote angiogenesis and alleviate myocardial infarction via the miR-31/FIH1/HIF-1α pathway in ischemic mouse models?
Exosomes from adipose-derived stem cells promote angiogenesis and improve cardiac function after myocardial infarction in mice via the miR-31/FIH1/HIF-1α pathway.
Answers are grounded in this paper and cite their sources.
Does not support clinical use of ASC exosomes; leaves open their role in ischemic angiogenesis.
Our previous study has revealed that exosomes from adipose-derived stem cells (ASCs) promote angiogenesis in subcutaneously transplanted gels by delivery of microRNA-31 (miR-31) which targets factor inhibiting hypoxia-inducible factor-1 (FIH1) in recipient cells. Here we hypothesized that ASC exosomes alleviate ischemic diseases through miR-31/FIH1/hypoxia-inducible factor-1α (HIF-1α) signaling pathway. Exosomes from ASCs were isolated by sequential centrifugations, and were characterized with nanoparticle tracking analysis, transmission electron microscopy, and immunoblotting analysis for exosomal markers. Results from laser imaging of ischemic mouse hindlimb revealed that exosomes enhanced the blood perfusion, and this enhancement was impaired when using miR-31-depleted exosomes. Immunohistochemistry analysis showed that administration of exosomes resulted in a higher arteriole density and larger CD31 + area in ischemic hindlimb than miR-31-delpleted exosomes. Similarly, knockdown of miR-31 in exosomes reduced the effects of the exosomes on increasing ventricular fraction shortening and CD31 + area, and on decreasing infarct size. Exosomes promoted endothelial cell migration and tube formation. These changes were attenuated when miR-31 was depleted in the exosomes or when FIH1 was overexpressed in the endothelial cells. Furthermore, the results from co-immunoprecipitation and luciferase reporter assay demonstrated that the effects of exosomes on elevating the binding of HIF-1α with co-activator p300 and enhancing HIF-1α activity were decreased when miR-31 was depleted in the exosomes or FIH1 was overexpressed. Our findings provide evidence that exosomes from ASCs promote angiogenesis in both mouse ischemic hindlimb and heart through transport of miR-31 which targets FIH1 and therefore triggers HIF-1α transcriptional activation.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2021) studied Myocardial infarction and ischemic diseases. Exosomes from adipose-derived stem cells vs. miR-31-depleted exosomes was evaluated on Angiogenesis, blood perfusion, infarct size, and ventricular fraction shortening. Exosomes from adipose-derived stem cells promoted angiogenesis and improved outcomes in mouse models of ischemic hindlimb and myocardial infarction via miR-31-mediated HIF-1α activation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: